Long-term clinical benefit from salvage EGFR tyrosine kinase inhibitors in advanced non-small-cell lung cancer patients with EGFR wild-type tumors
Titel:
Long-term clinical benefit from salvage EGFR tyrosine kinase inhibitors in advanced non-small-cell lung cancer patients with EGFR wild-type tumors
Auteur:
Koinis, F. Voutsina, A. Kalikaki, A. Koutsopoulos, A. Lagoudaki, E. Tsakalaki, E. Dermitzaki, E. K. Kontopodis, E. Pallis, A. G. Georgoulias, V. Kotsakis, A.